 |
Dimension Therapeutics
Last updated: August 12, 2024
Annalisa Jenkins, CEO
USA | Funding: $124.5M (+)
Website: http://dimensiontx.com
Dimension Therapeutics is developing novel, liver-directed gene therapy treatments for severe, rare genetic disorders. Dimension’s lead programs address significant medical needs for new therapies and include a wholly owned program in hemophilia B.
Website: http://dimensiontx.com
Dimension Therapeutics is developing novel, liver-directed gene therapy treatments for severe, rare genetic disorders. Dimension’s lead programs address significant medical needs for new therapies and include a wholly owned program in hemophilia B.
